grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

February 05, 2018

Omnicell's Automated Medication Dispensing System Receives Top KLAS Award for the 12th Consecutive Year

Download PDF

MOUNTAIN VIEW, Calif., Feb. 5, 2018 /PRNewswire/ -- Omnicell, Inc., (NASDAQ:OMCL), has earned top honors in the 2018 Best in KLAS: Software & Services report, including the prestigious 2018 Best in KLAS Automated Dispensing Cabinet designation. This award marks the 12th consecutive year that Omnicell has been recognized as the top vendor in this category by KLAS, an independent healthcare research firm, which uses ratings from thousands of healthcare professionals to determine the top-performing vendors.

Omnicell, Inc. logo. (PRNewsFoto/Omnicell, Inc.)

Omnicell'sWorkflowRx™ Carousel received the Category Leader distinction for the eighth year running in the Medication Carousels segment. The carousel increases productivity and reduces costs in the central pharmacy by providing greater control and tracking of medications, improved dispensing accuracy, and dynamic reordering of all pharmacy stock.

In addition, Omnicell was awarded Most Improved Medical Equipment Product for the i.v.STATION, with an 11% increase over the last year.

"We are proud to receive the top KLAS award for Automated Dispensing Cabinets for the 12th year, as customers continue to demonstrate their confidence in partnering with Omnicell to improve operational and financial performance, while enhancing quality of care," said Randall A. Lipps, founder, chairman, president, and CEO of Omnicell. "These honors fuel our continued focus on delivering innovative new solutions on the Omnicell platform, such as the next generation XT Series, to help our customers meet the ever-changing challenges of improving healthcare for all."

"Best in KLAS is more than a ranking. It is a recognition of vendors committed to delivering superior solutions," said Adam Gale, President of KLAS. "It gives voice to thousands of providers who are demanding better performance, usability, and interoperability in healthcare technology."

About KLAS

KLAS is a data-driven company on a mission to improve the world's healthcare by enabling provider and payer voices to be heard and counted. Working with thousands of healthcare professionals, KLAS collects insights on software, services and medical equipment to deliver reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly reflects the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.

Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

For more information about Omnicell, Inc. please visit


Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website,
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.


Cision View original content with multimedia:

SOURCE Omnicell, Inc.

News Provided by Acquire Media